Attachment 8 - Sample Client Letter for Past Performance_R.docx

DOCX document 16 KB Posted

Attached to
The CBER Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics (BEST 3)
Solicitation number
FDA-SOL-1224068
Issued by

About this file

This document contains a sample client letter and information about a federal contract opportunity with the Food and Drug Administration. The sample client letter is to be sent by an offering entity to its clients, requesting that the clients complete a past performance evaluation questionnaire as part of the entity's response to Solicitation Number FDA-SOL-1224068. The solicitation is for the CBER Biologics Effectiveness and Safety Initiative Number 3, which seeks data sources for surveillance of biologics. Offerors are required to identify past clients and obtain completed questionnaires from them to submit as part of the proposal by the closing date of July 23, 2020. The contract will be awarded by the FDA's Office of Acquisition and Grant Services.

View the file

Other files

Show all 12

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

ATTACHMENT 8 – SAMPLE CLIENT LETTER

Solicitation Number: FDA-SOL-1224068

Dear Client, We are currently responding to Solicitation Number FDA-SOL-1224068 for the Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative: Data Sources for Surveillance of Biologics.

The FDA placed emphasis on past performance as a key source selection factor and requiring that clients of entities responding to their solicitations be identified and their participation in the evaluation process be requested.

Therefore, enclosed is a Past Performance Evaluation Questionnaire for your completion. We are requesting that you complete the questionnaire and send it via email to suzanne.martella@fda.hhs.gov no later than the closing date/time of the solicitation: 12:00 PM Central Time on July 23, 2020:

If you have questions regarding the attached questionnaire, or require assistance, please contact Suzanne Martella, FDA Contract Specialist at 870-543-7540 or suzanne.martella@fda.hhs.gov.

We thank you for your prompt response in this matter.

Sincerely, {Offering Entity}

File details come from the government source that posted it. Updated .